Benitec Announces Supreme Court of Queensland Approval for Redomicile
MELBOURNE, Australia, March 30, 2020 /PRNewswire/ --Benitec Biopharma Limited (Benitec or the "Company") (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland ("Court") has approved the scheme of arrangement to redomicile the Benitec group from Australia to the United States of America.
- MELBOURNE, Australia, March 30, 2020 /PRNewswire/ --Benitec Biopharma Limited (Benitec or the "Company") (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland ("Court") has approved the scheme of arrangement to redomicile the Benitec group from Australia to the United States of America.
- Benitec has lodged an official copy of the Court orders with the Australian Securities and Investments Commission.
- Benitec shares have been suspended from trading on ASX from the close of trading on Monday, March 30, 2020 (AEST).
- Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is a clinical-stage biotechnology company focused on the development of novel genetic medicines.